Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BIT/REC stock hub

BIT/REC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BIT/RECis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

10.2B

Borsa Italiana

Market data

Live price

Current market quote for this ticker.

Current price

BIT/REC

In the news

Latest news · BIT/REC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20.1

P25 13P50 15.3P75 18.4

Trailing P/E23.6

P25 14.4P50 21.2P75 24.6

ROE23.4

P25 3.1P50 8.5P75 13.3

ROIC15.1

P25 5.3P50 8.5P75 15.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BIT/REC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

248

Groups with data

Currency

EUR

Showing 248 of 248 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Italy
Country code	IT
Employees	4,693
Employees Change	110%
Employees Change Percent	2.4
Enterprise value	EUR 12.3B
Exchange	Borsa Italiana
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	IT0003828271
Last refreshed	2026-05-10
Market cap	EUR 10.2B
Price	EUR 50
Price currency	EUR
Rev Per Employee	562,609.15x
Sector	Healthcare
Sic	2834
Symbol	bit/REC
Website	https://recordati.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.34%
EV Earnings	27.64x
EV/EBIT	15.63x
EV/EBITDA	12.38x
EV/FCF	22x
EV/Sales	4.68x
FCF yield	5.46%
Forward P/E	20.13x
P/B ratio	5.32x
P/E ratio	23.57x
P/S ratio	3.9x
PE Ratio10 Y	24.64x
PE Ratio3 Y	25.09x
PE Ratio5 Y	25.63x
PEG ratio	1.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	29.95%
EBITDA Margin	37.31%
FCF margin	21.29%
Gross margin	70.82%
Gross Profit	EUR 1.9B
Gross Profit Growth	13.23%
Gross Profit Growth Q	19.64%
Gross Profit Growth3 Y	11.54%
Gross Profit Growth5 Y	12.22%
Net Income	EUR 443.6M
Net Income Growth	6.51%
Net Income Growth Q	50.23%
Net Income Growth Quarters	1%
Net Income Growth Years	3%
Net Income Growth3 Y	12.41%
Net Income Growth5 Y	4.56%
Pretax Margin	22.2%
Profit Margin	16.94%
Profit Per Employee	EUR 95,321
Profitable Years	23
ROA	9.44
Roa5y	9.94
ROCE	18.67
ROE	23.37
Roe5y	24.24
ROIC	15.09
Roic5y	16.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.77%
Cagr15y	17.03%
Cagr1y	-3.22%
Cagr20y	14.38%
Cagr3y	8.29%
Cagr5y	4.7%
Div CAGR10	8.37%
Div CAGR3	5.23%
Div CAGR5	5%
EPS Growth	6.48
EPS Growth Q	50
EPS Growth Quarters	1
EPS Growth Years	3
EPS Growth3 Y	12.39
EPS Growth5 Y	4.55
FCF Growth	4.54%
FCF Growth Q	60.14%
FCF Growth3 Y	8.39%
FCF Growth5 Y	7.83%
OCF Growth	4.73%
OCF Growth Q	49.68%
OCF Growth10 Y	9.21%
OCF Growth3 Y	8.94%
OCF Growth5 Y	8.14%
Revenue Growth	11.82x
Revenue Growth Q	10.65x
Revenue Growth Quarters	19x
Revenue Growth Years	5x
Revenue Growth3 Y	12.21x
Revenue Growth5 Y	12.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.5
Assets	EUR 5.3B
Cash	EUR 428.8M
Current Assets	EUR 1.7B
Current Liabilities	EUR 1.1B
Debt	EUR 2.5B
Debt EBITDA	EUR 2.5
Debt Equity	EUR 1.29
Debt FCF	EUR 4.44
Equity	EUR 1.9B
Interest Coverage	7.93
Liabilities	EUR 3.3B
Long Term Assets	EUR 3.6B
Long Term Liabilities	EUR 2.3B
Net Cash	EUR -2B
Net Cash By Market Cap	EUR -20
Net Debt EBITDA	EUR 2.09
Net Debt Equity	EUR 1.06
Net Debt FCF	EUR 3.67
Tangible Book Value	EUR -1.2B
Tangible Book Value Per Share	EUR -5.98
WACC	6.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.59
Inventory Turnover	1.46
Net Working Capital	EUR 538.5M
Quick ratio	1.05
Working Capital	EUR 625.2M
Working Capital Turnover	EUR 4.41

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.4%
Dividend Growth	5.51%
Dividend Growth Years	13%
Dividend per share	EUR 1.34
Dividend Years	22
Dividend Yield	2.68%
Ex Div Date	2026-05-18
Last Dividend	EUR 0.71
Payout Frequency	Semi-Annual
Payout Ratio	60.31%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	178.08%
1Y total return	-3.22%
200-day SMA	49.94
3Y total return	26.98%
50-day SMA	48.24
50-day SMA vs 200-day SMA	50under200
5Y total return	25.81%
All Time High	60.95
All Time High Change	-17.97%
All Time High Date	2025-02-13
All Time Low	0.36
All Time Low Change	13,937.06%
All Time Low Date	1993-11-23
ATR	0.96
Beta	0.52
Beta1y	0.65
Beta2y	0.63
Ch YTD	3.01
High	50.4
High52	55.35
High52 Date	2025-06-12
High52ch	-9.67%
Low	49.2
Low52	43.76
Low52 Date	2026-03-19
Low52ch	14.26%
Ma50ch	3.64%
Price vs 200-day SMA	0.13%
RSI	56.82
RSI Monthly	50.36
RSI Weekly	53.15
Sharpe ratio	-0.22x
Sortino ratio	-0.02
Total Return	3.08%
Tr YTD	3.01
Tr15y	957.95%
Tr1m	1.79%
Tr1w	0.24%
Tr3m	5.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 784.2M
Operating Income Growth	12.3
Operating Income Growth Q	47.79
Operating Income Growth3 Y	12.93
Operating Income Growth5 Y	10.53
Operating margin	29.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	108,423,256%
Net Borrowing	-26,966,000
Shares Insiders	0.08%
Shares Institutions	26.48%
Shares Out	204,355,889
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 540.9M
Average Volume	360,160.85x
Bv Per Share	9.39
CAPEX	EUR -39.4M
Ch10y	119
Ch15y	588.7
Ch1m	1.79
Ch1w	0.24
Ch1y	-5.66
Ch20y	666.9
Ch3m	5.93
Ch3y	17.7
Ch5y	11.06
Ch6m	0.56
Change	0.4%
Change From Open	-0.4
Close	49.8
Days Gap	0.8
Depreciation Amortization	192,802,000
Dollar Volume	15,226,300
Earnings Date	2026-05-12
EBIT	EUR 784.2M
EBITDA	EUR 977M
EPS	EUR 2.12
F Score	7
FCF	EUR 557.5M
FCF EV Yield	4.55x
FCF Per Share	EUR 2.73
Financing CF	-407,016,000
Fiscal Year End	December
Founded	1,926
Goodwill	795,680,000
Graham Number	21.42084
Graham Upside	-57.16
Income Tax	EUR 137.7M
Investing CF	-80,836,000
Is Primary Listing	1
Last Earnings Date	2026-03-19
Last Report Date	2025-12-31
Last Split Date	2005-04-18
Last Split Type	Forward
Lynch Fair Value	EUR 10.85
Lynch Upside	-78.29
Ma150	49.11
Ma150ch	1.81%
Ma20	49.67
Ma20ch	0.66%
Net CF	106,401,000
Next Earnings Date	2026-05-12
Open	50.2
P FCF Ratio	18.33
P OCF Ratio	17.12
Payment Date	2026-05-20
Position In Range	66.67
Ppne	222,324,000
Price Date	2026-05-08
Price EBITDA	EUR 10.46
Relative Volume	0.88x
Revenue	2,618,383,000x
SBC By Revenue	0.63x
Share Based Comp	16,545,000
Tax By Revenue	5.26x
Tax Rate	23.68%
Tr20y	1,369.01%
Tr6m	1.83%
Volume	304,526
Z Score	3.7

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BIT/REC dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.7%

$1.34 annual per share

Payout ratio

+60.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.0%

13 consecutive years of growth

Total shareholder yield

+3.1%

Next ex-dividend date: 2026-05-18

Performance

BIT/REC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BIT/REC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.5%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

BIT/REC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.8

Neutral momentum band

Price vs 200-day MA

+0.1%

50/200-day relationship not available

Beta (5Y)

0.52

Less volatile than the market

Sharpe ratio

-0.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BIT/REC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/REC stock rating?

bit/REC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/REC analysis?

The full report lives at /stocks/bit/REC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/REC?

The latest report frames bit/REC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/REC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.